Avoid common mistakes on your manuscript.
Erratum to: Purinergic Signalling
DOI 10.1007/s11302-007-9078-7
In Table 1, at line 8 after P2Y14: “IP3” should be changed to “↓cAMP”.
In Fig. 2, lower left in the VSMC: P2Y12 should be P2Y2.
Functional roles of P2 receptors in the atherosclerotic inflammatory plaque and during restenosis. See text for details. Purines and pyrimidines acting on P2 receptors stimulate vascular inflammation both by actions on the endothelial cell (EC) and by effects on inflammatory cells. Furthermore, they stimulate vascular smooth muscle cell (VSCM) proliferation, the conversion to synthetic phenotype and production of matrix proteins. Mitogenic P2 receptors are upregulated by growth factors and cytokines. IL interleukin, MCP-1 monocyte chemoattractant protein-1, ICAM-1 intercellular adhesion molecule-1, TSP thrombospondin, IDO indoleamine 2,3-dioxygenase
Author information
Authors and Affiliations
Corresponding author
Additional information
The online version of the original article can be found at: http://dx.doi.org/10.1007/s11302-007-9078-7.
Rights and permissions
Open Access This is an open access article distributed under the terms of the Creative Commons Attribution Noncommercial License ( https://creativecommons.org/licenses/by-nc/2.0 ), which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
About this article
Cite this article
Erlinge, D., Burnstock, G. P2 receptors in cardiovascular regulation and disease. Purinergic Signalling 4, 85–87 (2008). https://doi.org/10.1007/s11302-007-9092-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11302-007-9092-9